Using millers anaesthesia and Morgan anaesthesia books teach me from basics to advance with easy to read and understand format about Pulmonary function tests

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Loading Image

Finding Sources

Reading File

Loading Image

Reading File

I now have rich, comprehensive content from both Miller's and Morgan's textbooks. Let me compile the complete, well-structured educational guide.

Pulmonary Function Tests (PFTs) - A Complete Guide

From Basics to Advanced Anaesthetic Applications

Sources: Miller's Anesthesia 10e & Morgan and Mikhail's Clinical Anesthesiology 7e

📘 PART 1: WHY PFTs MATTER IN ANAESTHESIA

Postoperative pulmonary complications (PPCs) are among the most common sources of perioperative morbidity and healthcare cost after major surgery. A thorough history and physical exam remain the cornerstone of preoperative pulmonary assessment - but PFTs add critical objective data when:

The patient has known lung disease (COPD, asthma, ILD)
Surgery involves the thorax (lung resection especially)
There are unexplained symptoms - dyspnoea, exercise intolerance
ICU/critical care decision-making is needed

"In patients with known risk factors, preexisting lung diseases, and thoracic surgery candidates, pulmonary function tests complement preoperative evaluation and risk stratification." - Miller's Anesthesia 10e

📘 PART 2: LUNG VOLUMES - THE FOUNDATION

Before understanding PFTs, you must know lung volumes. This is the map of the respiratory system:

Lung Volumes Diagram - Miller's Anesthesia

Fig. 12.23 - Lung Volumes (Miller's Anesthesia 10e, p.1306)

Volume/Capacity	Definition	Normal Value
Tidal Volume (VT)	Air moved in/out with each normal breath	~500 mL
Inspiratory Reserve Volume (IRV)	Extra air you can inhale beyond VT	~3000 mL
Expiratory Reserve Volume (ERV)	Extra air you can exhale beyond VT	~1100 mL
Residual Volume (RV)	Air remaining after maximal exhalation - cannot be measured by spirometry	~1200 mL
Total Lung Capacity (TLC)	All air in the lungs at maximum inspiration	~6000 mL
Vital Capacity (VC)	Maximum volume exhaled after maximum inhalation	~4800 mL
Functional Residual Capacity (FRC)	Volume remaining after normal exhalation (= ERV + RV)	~2300 mL
Inspiratory Capacity (IC)	Maximum air inhaled from FRC	~3500 mL

The Special Importance of FRC

Morgan's (Ch. 23) describes FRC beautifully: "The lung volume at the end of a normal exhalation is called functional residual capacity. At this volume, the inward elastic recoil of the lung approximates the outward elastic recoil of the chest wall - thus defining the point from which normal breathing takes place."

Factors that REDUCE FRC (important for anaesthetists!):

Obesity - reduced chest wall compliance + increased abdominal pressure on diaphragm
Female sex - ~10% lower than males
Supine position - abdominal contents push up against diaphragm (greatest change 0° to 60°)
Laparoscopy/Pregnancy/Ascites - increased intraabdominal pressure
Restrictive lung disease - reduced lung/chest wall compliance

FRC and General Anaesthesia

Miller's (p.1308-1309) highlights a critical point every anaesthetist must know:

"Resting lung volume (FRC) is reduced by almost 1 L by moving from upright to supine position; induction of anesthesia further decreases the FRC by approximately 0.5 L. This reduces the FRC from approximately 3.5 L to 2 L, a value close to RV."

This ~20% fall in FRC under general anaesthesia (whether IV or inhalational, controlled or spontaneous) is a major cause of intraoperative hypoxaemia - because it promotes airway closure and atelectasis.

📘 PART 3: SPIROMETRY - THE WORKHORSE TEST

Spirometry is the single most important and commonly used PFT. It is the preferred diagnostic test for both COPD and asthma.

How It Is Performed

Patient inhales to Total Lung Capacity (TLC)
Exhales as forcefully and completely as possible into the spirometer
Measurements are taken from the volume-time curve

Fig. 12.21 - Spirometry Tracing (Miller's Anesthesia 10e, p.1305) - Note: shaded areas (FRC and RV) cannot be measured by spirometry alone.

Key Spirometry Parameters

Parameter	Definition	Significance
FVC (Forced Vital Capacity)	Total volume exhaled forcefully	Reduced in both obstruction AND restriction
FEV₁ (Forced Expiratory Volume in 1 sec)	Volume exhaled in the first second	Most important single value
FEV₁/FVC ratio	Proportion of FVC exhaled in 1 second	KEY ratio to distinguish obstruction vs restriction
FEF 25-75%	Mean flow during middle half of FVC	Sensitive indicator of small airway disease
Peak Expiratory Flow (PEF)	Maximum flow rate during forced expiration	Used for asthma monitoring

Interpreting Spirometry - The Golden Rules

STEP 1: Look at FEV₁/FVC ratio
    - < 0.70 (post-bronchodilator) = OBSTRUCTIVE pattern
    - ≥ 0.70 with reduced FVC = RESTRICTIVE pattern (confirm with lung volumes)

STEP 2: If Obstructive - grade severity by FEV₁ % predicted:
    - FEV₁ ≥ 80%  → Mild (GOLD 1)
    - FEV₁ 50-79% → Moderate (GOLD 2)
    - FEV₁ 30-49% → Severe (GOLD 3)
    - FEV₁ < 30%  → Very Severe (GOLD 4)

STEP 3: Check bronchodilator reversibility
    - Improvement in FEV₁ > 12% AND > 200 mL = reversible = suggests ASTHMA
    - No significant reversibility = COPD

📘 PART 4: OBSTRUCTIVE vs RESTRICTIVE PATTERNS

Obstructive Pattern (e.g., COPD, Asthma)

FEV₁/FVC < 0.70
FEV₁ reduced
FVC may be normal or reduced
TLC increased (air trapping/hyperinflation)
RV increased

Miller's (p.3823-3826): "A diagnosis of COPD is determined by spirometry with FEV₁/FVC ratio <0.7 post-bronchodilator (confirming non-reversibility of airway obstruction)."

For Asthma: Miller's (p.3945) - "Typical findings are a reduction in FEV₁/FVC - with a ratio below 0.7 indicative of airflow obstruction. Importantly, normal initial PFT results do not necessarily exclude asthma." In this case, a methacholine challenge test or trial of bronchodilator therapy should be performed.

Restrictive Pattern (e.g., Pulmonary Fibrosis, Obesity, NMD)

FEV₁/FVC preserved (≥ 0.70)
FVC reduced
TLC reduced (confirmed by full lung volume testing)
Both FEV₁ and FVC proportionally reduced

📘 PART 5: FLOW-VOLUME LOOPS - READING THE CURVE

The flow-volume loop plots flow (y-axis) against volume (x-axis) and gives information that a simple time-volume curve cannot.

Fig. 12.22 - Flow-Volume Loop Patterns (Miller's Anesthesia 10e, p.1305)

Pattern	Inspiratory Limb	Expiratory Limb	Cause
Variable Extrathoracic	Flattened (truncated)	Normal	Vocal cord dysfunction, tracheal stenosis above thoracic inlet
Variable Intrathoracic	Normal	Flattened	Tracheomalacia, intrathoracic tracheal mass
Fixed Obstruction	Flattened both	Flattened both	Rigid tracheal stenosis (e.g., post-intubation)
Obstructive (COPD/Asthma)	Normal	Scooped-out/concave shape	Small airway collapse on expiration
Restrictive	Normal shape, smaller loop	Normal shape, smaller loop	Reduced lung volume

Anaesthetic pearl: A flattened inspiratory limb suggests a difficult airway or tracheal pathology - important pre-induction consideration!

📘 PART 6: LUNG VOLUME MEASUREMENT

RV and FRC cannot be measured by spirometry alone. Three methods exist:

1. Body Plethysmography (Most Accurate)

Patient sits in airtight, constant-volume "body box"
Makes inspiratory efforts against a closed shutter
Applies Boyle's Law: P₁V₁ = P₂V₂
As thoracic volume expands, box pressure rises - allowing calculation of FRC/RV
Most accurate - includes all gas (even trapped/non-communicating areas)

2. Nitrogen Washout

Patient breathes 100% oxygen
Nitrogen is washed out of lungs and measured in exhaled air
N₂ = 80% of lung gas - so total lung gas = measured N₂ volume ÷ 0.80
Limitation: underestimates in patients with poorly-communicating lung units (emphysema, bullae)

3. Helium Dilution

Based on conservation of mass of inert helium gas
Limitation: same as nitrogen washout - misses poorly-communicating zones

Clinical tip: In emphysema with bullae, there can be a large discrepancy between plethysmography (larger, more accurate) and helium dilution (underestimates) - this discrepancy itself is diagnostically useful. (Miller's block20)

📘 PART 7: DIFFUSING CAPACITY (DLCO)

What Is DLCO?

DLCO (Diffusing Capacity for Carbon Monoxide) measures the functional capillary surface area available for gas exchange.

Miller's (p.1303-1304) explains the principle: "Because of the high affinity of CO for haemoglobin, the partial pressure of dissolved CO in the blood remains very low, so CO transfer is not limited by pulmonary blood flow, but only by membrane thickness."

What DLCO Tells You

DLCO is governed by:

Surface area of the alveolar-capillary membrane
Thickness of the membrane (inverse relationship)
Pressure gradient across the membrane
Solubility of the gas

DLCO Result	Interpretation	Common Causes
Reduced	Emphysema, ILD/Fibrosis, Pulmonary HTN, Anaemia	Gas exchange surface lost or membrane thickened
Normal	Simple airways disease (asthma)	Membrane intact
Elevated	Pulmonary haemorrhage, Polycythaemia, Exercise	Increased RBC available for CO binding

DLCO Anaesthetic Thresholds (Miller's p.1304)

DLCO < 60% of predicted - associated with increased risk of postoperative pulmonary complications and is an indication for further preoperative risk assessment using exercise testing
DLCO (ppoDLCO) < 30-40% predicted - threshold for increased risk in thoracic surgery

📘 PART 8: CLOSING CAPACITY - A UNIQUE ANAESTHETIC CONCEPT

Morgan's (p.924-926) explains this concept which is essential for anaesthetists:

Closing capacity = the lung volume at which small, non-cartilaginous airways in dependent lung zones begin to collapse during expiration.

Nitrogen Single-Breath Test (Morgan's Fig. 23-6)

Inhale 100% O₂ from RV to TLC
Exhale slowly - measure expired N₂ concentration
Phase I: 0% N₂ (anatomic dead space)
Phase II: Mixed gas
Phase III: "Alveolar plateau" - should be flat; steep slope = non-uniform distribution
Phase IV: N₂ concentration rises sharply = closing volume - dependent airways starting to close

Why This Matters

Closing capacity is normally below FRC (airways stay open). But:

In elderly patients and obese patients, closing capacity rises above FRC - even while awake
Under general anaesthesia, FRC falls ~0.5 L - this may bring FRC below closing capacity
Result: airway closure during normal tidal breathing → V/Q mismatch → hypoxaemia

Morgan's summarizes: "At lower lung volumes, alveoli in dependent areas continue to be perfused but are no longer ventilated; the resulting intrapulmonary shunting of deoxygenated blood (venous admixture) promotes hypoxaemia."

📘 PART 9: CARDIOPULMONARY EXERCISE TESTING (CPET)

CPET is the gold standard for integrating all three systems: respiratory, cardiovascular, and musculoskeletal.

Miller's (p.1307): "CPET involves brief incremental exercise (treadmill or bike) with continuous monitoring of ECG, pulse oximetry, respiratory rate, exhaled gases, airflow, and volume."

Key CPET Parameters

Parameter	Definition	Risk Threshold
VO₂max	Maximum oxygen consumption at peak exercise - overall cardiorespiratory fitness	< 15 mL/kg/min = increased PPC risk
Anaerobic Threshold (AT)	VO₂ above which VCO₂ rises disproportionately - sustainable exercise capacity	< 10 mL/kg/min = increased risk
VE/VCO₂ ratio	Efficiency of gas exchange; reflects V/Q matching and dead space	Elevated ratio predicts PPCs more accurately than VO₂max

📘 PART 10: PREOPERATIVE PFT RISK STRATIFICATION

General Surgery

Miller's (p.3868): "PFTs may be indicated for diagnosis or management decisions but have NOT been shown to predict postoperative pulmonary complications (PPCs) except for patients having lung resections."

Key thresholds for general surgical risk:

FEV₁ < 60% predicted - associated with increased risk of serious PPCs
DLCO < 60% predicted - triggers referral for exercise testing
Baseline PaCO₂ > 45 mmHg - higher risk for postoperative morbidity

Thoracic Surgery: The "Three-Legged Stool"

For lung resection surgery, Miller's (p.3444) describes the framework:

"No single test of respiratory function has shown adequate validity as a sole preoperative assessment. Prior to surgery, an estimate of respiratory function in all three areas - lung mechanics, parenchymal function, and cardiopulmonary interaction - should be made."

The Three Legs:

Leg	Best Test	Risk Threshold
Respiratory Mechanics	ppoFEV₁ (predicted postoperative FEV₁)	< 30-40% predicted
Lung Parenchymal Function	ppoDLCO (predicted postoperative DLCO)	< 30-40% predicted
Cardiopulmonary Interaction	VO₂max (CPET)	< 15 mL/kg/min

Predicted Postoperative Values (ppo)

The ppo value estimates function remaining after resection. The formula accounts for how much functioning lung is being removed.

Preoperative Assessment Algorithm - Miller's Anesthesia

Fig. 49.2 - Preoperative Respiratory Investigation Algorithm for Pulmonary Resection (Miller's Anesthesia 10e, p.7080)

Reading the Algorithm:

Functional capacity > 2 METs?
- Yes → proceed to spirometry: ppoFEV₁ and ppoDLCO
- No → defer for medical consultation and optimization
Both ppoFEV₁ AND ppoDLCO > 60% → Proceed safely
Either value 30-60% → Simple exercise testing (6-minute walk test)
- 6MWT > 400 m → Proceed (increased risk, acceptable)
- 6MWT < 400 m → Full CPET
Either value < 30% → Full CPET directly
- VO₂max ≥ 10 mL/kg/min → Increased risk, proceed with caution
- VO₂max < 10 mL/kg/min → High risk - consider alternative therapies

VATS vs Open Thoracotomy: Shifting Thresholds

Miller's (p.3466): "The threshold for increased risk in ppoFEV₁ for lobectomy appears to have shifted from < 40% for open thoracotomy to < 30% for VATS."

This means patients previously deemed too high-risk for open surgery may be acceptable for minimally invasive resection.

📘 PART 11: EXTUBATION DECISIONS AFTER PULMONARY RESECTION

Miller's (p.3491) provides clear guidance:

ppoFEV₁	Criteria for OR Extubation
> 40%	Can usually extubate in OR if patient is "AWaC" (Alert, Warm, and Comfortable)
30-40%	Extubate in OR if exercise tolerance AND lung parenchymal function above risk thresholds
20-30%	Consider early extubation if thoracic epidural analgesia used OR if VATS performed
< 20%	Staged weaning from mechanical ventilation postoperatively

📘 PART 12: DISEASE-SPECIFIC PFT PATTERNS SUMMARY

Disease	FEV₁/FVC	FEV₁	FVC	TLC	DLCO	Key Feature
COPD	↓ (<0.70)	↓↓	↓ or N	↑ (hyperinflation)	↓ (emphysema)	Irreversible obstruction
Asthma	↓	↓	N	N	N	Reversible with bronchodilator
Pulmonary Fibrosis	N or ↑	↓	↓↓	↓↓	↓↓	Restrictive + impaired diffusion
Emphysema	↓	↓	N or ↓	↑↑	↓↓	Air trapping, loss of alveolar surface
Neuromuscular Disease	N	↓	↓↓	↓	N	Restrictive, normal diffusion
Obesity	N	↓	↓	↓	N	Restrictive, ↓ FRC, ↑ closing capacity
Pulmonary Hypertension	N	N	N	N	↓	Isolated DLCO reduction

📘 PART 13: PRACTICAL ANAESTHETIC IMPLICATIONS SUMMARY

Situation	What PFTs Tell You	Anaesthetic Action
COPD patient for surgery	Severity of obstruction	Optimize bronchodilators, plan for possible ICU postop
Lung resection candidate	ppoFEV₁, ppoDLCO	Use three-legged stool; may need CPET
Unexplained dyspnoea	Obstructive vs restrictive pattern	Tailor further workup
Upper airway mass	Flow-volume loop shape	Anticipate difficult airway; have plan for obstruction
Pre-induction in obese patient	↓ FRC, ↑ closing capacity	Pre-oxygenation in head-up position; PEEP titration
Post-op respiratory failure	Baseline FEV₁, DLCO	Guides weaning decisions, extubation readiness
Bullous disease	Plethysmography vs dilution discrepancy	Avoid N₂O; cautious with high airway pressures
Asthma	Reversibility testing	PFTs have limited perioperative prognostic value in well-controlled asthma

📘 PART 14: QUICK-REFERENCE MEMORY TABLES

Critical PFT Thresholds for Anaesthesia

Test	Threshold	Meaning
FEV₁	< 60% predicted	Increased risk of PPCs
FEV₁/FVC	< 0.70	Obstructive disease
DLCO	< 60% predicted	Refer for exercise testing
ppoFEV₁	< 30-40%	High risk for lung resection
ppoDLCO	< 30-40%	High risk for lung resection
VO₂max	< 15 mL/kg/min	Increased PPC risk
VO₂max	< 10 mL/kg/min	Very high risk - consider alternatives
AT	< 10 mL/kg/min	Increased surgical risk
PaCO₂	> 45 mmHg	Higher postoperative morbidity risk

Methods to Measure FRC (Cannot Use Spirometry)

Method	Principle	Accuracy in Emphysema
Body Plethysmography	Boyle's Law	Best - includes trapped gas
Nitrogen Washout	Conservation of N₂ mass	Underestimates (misses trapped gas)
Helium Dilution	Conservation of He mass	Underestimates (misses trapped gas)

Sources

Miller's Anesthesia, 2-Volume Set, 10e - Chapters 12 (Respiratory Physiology), 29 (Preoperative Assessment), 49 (Thoracic Surgery), 52 (Vascular Surgery)
Morgan and Mikhail's Clinical Anesthesiology, 7e - Chapter 23 (Respiratory Physiology and Anesthesia)

Using millers, Morgan and barasch discuss in detail about Acute post operative pain, Fluid management in major abdominal surgery, anaesthetic management in Colles fracture and Peripheral vascular diseases. Use the sources that I’ve shared for the formatting of the answers. Use millers, Morgan and barasch anaesthesia books and discuss all the important aspects

Finding Sources

Reading File

Finding Sources

Reading File

Complete Anaesthesia Guide

Acute Postoperative Pain | Fluid Management in Major Abdominal Surgery | Colles Fracture | Peripheral Vascular Disease

Sources: Miller's Anesthesia 10e | Morgan and Mikhail's Clinical Anesthesiology 7e | Barash Clinical Anesthesia 9e

🔴 TOPIC 1: ACUTE POSTOPERATIVE PAIN

📘 PART 1: WHY POSTOPERATIVE PAIN MATTERS

Globally, over 300 million surgical procedures are performed each year. Despite significant advances in knowledge and treatment of acute pain, the management of acute postoperative pain remains less than optimal.

"Inadequate relief of postoperative pain has adverse physiologic effects that can contribute to significant morbidity and mortality, resulting in the delay of patient recovery and return to daily activities." - Barash 9e, Ch. 55

In 2016, a multisociety collaborative (ASA + ASRA + APS) published treatment guidelines for acute postoperative pain. A further update in 2021 established 7 guiding principles (Barash 9e, Table 55-1):

Conduct a preoperative evaluation including psychologic conditions, history of chronic pain, substance abuse, and previous pain treatment responses
Use a validated pain assessment tool to track responses and adjust plans
Offer multimodal analgesia - medications + nonpharmacologic interventions
Provide patient- and family-centred education on treatment options
Educate on proper storage and disposal of opioids and tapering
Adjust the plan based on adequacy of pain relief and presence of adverse events
Have access to appropriate resources

📘 PART 2: NEUROBIOLOGY OF PAIN - THE BASICS

Understanding pain mechanisms is essential for targeted multimodal therapy.

The Four Elements of Pain Processing (Barash 9e, Fig. 55-6)

1. TRANSDUCTION
   Noxious thermal / chemical / mechanical stimulus
   → converted to action potential at nociceptors (Aδ and C fibers)

2. TRANSMISSION
   Action potential conducted via:
   → 1st-order neuron: periphery to dorsal horn (DRG)
   → 2nd-order neuron: dorsal horn to thalamus
   → 3rd-order neuron: thalamus to cortex

3. MODULATION
   Dorsal horn is the KEY site
   ↓ Inhibition: GABA, glycine, descending norepinephrine/serotonin/endorphins
   ↑ Augmentation: Central sensitization ("wind-up")

4. PERCEPTION
   Integration in somatosensory and limbic cortices

"Traditional analgesic therapies have only targeted pain perception. A multimodal approach should target all four elements of the pain-processing pathway." - Barash 9e, p.4645

Peripheral Sensitization

Tissue damage activates:

Macrophages, mast cells, lymphocytes, platelets
Antidromic release of substance P and glutamate from C fibers
Chemical milieu: prostaglandins, bradykinin, serotonin, histamine, cytokines
Result: primary hyperalgesia (exaggerated response at the injury site)

Central Sensitization

"Wind-up" phenomenon: repetitive C-fiber stimulation of WDR neurons in dorsal horn
Hyperalgesia: exaggerated response to a normally painful stimulus
Allodynia: painful response to a normally non-painful stimulus

📘 PART 3: ACUTE EFFECTS OF UNCONTROLLED POSTOPERATIVE PAIN

Miller's (Ch. 77) provides a comprehensive breakdown:

1. Neuroendocrine Stress Response

Nociceptive stimuli → hypothalamic-pituitary-adrenocortical + sympathoadrenal activation:

↑ Catecholamines, cortisol, ACTH, ADH, glucagon, aldosterone, renin, angiotensin II
↓ Anabolic hormones
Result: Na/water retention, hyperglycaemia, free fatty acids, negative nitrogen balance, hypermetabolic/catabolic state

2. Cardiovascular Effects

↑ Sympathetic tone → tachycardia, hypertension, increased myocardial O₂ demand
Hypercoagulability: ↓ natural anticoagulants, ↑ procoagulants, ↑ platelet reactivity
Risk of: DVT, vascular graft failure, myocardial ischaemia

3. Respiratory Effects

Inhibitory spinal reflex on phrenic nerve → reduced diaphragmatic function
↓ Tidal volumes, inadequate cough
Especially harmful after upper abdominal and thoracic surgery
Risk of: postoperative pulmonary complications, atelectasis, pneumonia

4. Gastrointestinal Effects

Spinal reflex inhibition of GI motility
Postoperative ileus - delayed return of bowel function

5. Immunological Effects

Postoperative immunosuppression correlates with severity of surgical injury
Hyperglycaemia from stress response → poor wound healing + depression of immune function

6. Psychological Effects

Patient dissatisfaction with surgical experience
Adverse psychological consequences

📘 PART 4: CHRONIC PERSISTENT POSTSURGICAL PAIN (CPSP)

Miller's (p.11692) highlights this under-recognised problem:

Incidence: 10% to 65% of postoperative patients (depending on surgery type)
Severe CPSP: 2% to 10%

Surgery	CPSP Incidence
Limb amputation	30-83%
Thoracotomy	22-67%
Sternotomy	27%
Breast surgery	11-57%
Gallbladder surgery	Up to 56%

"Poorly controlled acute postoperative pain is an important predictive factor in the development of CPSP. The transition from acute to chronic pain occurs very quickly, and long-term behavioural and neurobiological changes occur much sooner than was previously thought." - Miller's Anesthesia 10e, p.11692

Key point: Noxious stimuli can express new genes in the dorsal horn within 1 hour - sufficient to alter behaviour within the same timeframe. The intensity of acute postoperative pain is a significant predictor of CPSP.

📘 PART 5: PREVENTIVE ANALGESIA

Miller's (p.11693) clarifies the evolution of terminology:

Preemptive analgesia: the older concept - intervention before surgical incision prevents central sensitization from incisional injury only
Preventive analgesia: the broader, current concept - encompasses the entire perioperative period to prevent central sensitization from incisional AND inflammatory injury

The idea: reduce or eliminate the peripheral nociceptive barrage reaching the CNS throughout the perioperative period to blunt central sensitization.

📘 PART 6: MULTIMODAL ANALGESIA - THE CORNERSTONE

"Multimodal analgesia combines different classes of medications with different pharmacological mechanisms of action, resulting in additive or synergistic effects to reduce postoperative pain while reducing analgesic dosage and associated side effects." - Morgan's 7e, Ch. 48

The Components

1. NSAIDs / COX-2 Inhibitors

Inhibit cyclooxygenase (COX) → ↓ prostaglandin synthesis
Both peripheral (sensitization) and spinal COX inhibition
Benefits: ↓ pain intensity, ↓ opioid requirements, ↓ PONV, ↓ sedation, ↓ urinary retention
Cautions: GI bleeding (non-selective), ↓ renal function, anastomotic healing concerns
COX-2 inhibitors (celecoxib): fewer GI effects, minimal platelet inhibition; celecoxib confirmed cardiovascularly non-inferior to ibuprofen/naproxen (24,081-patient RCT - Miller's p.11712)

2. Acetaminophen (Paracetamol)

Central mechanism: activates descending serotonergic pathways + inhibits prostaglandin synthesis
Analgesic effect 20-30% less than NSAIDs, but safer profile
IV formulation approved - useful when oral route unavailable
When combined with NSAIDs: ↓ pain scores + ↓ opioid consumption significantly
Max dose: 4 g/day in adults; avoid in acute decompensated liver failure
Preoperative dosing: 975 mg IV (Barash 9e, Table 55-6)

3. Gabapentinoids (Gabapentin / Pregabalin)

Mechanism: bind voltage-gated calcium channel α2δ subunit in dorsal horn
Single preoperative dose: ↓ postoperative pain and opioid consumption in first 24h
May reduce incidence of chronic post-surgical pain
Side effects: sedation, dizziness (particularly in elderly - risk of falls)
Gabapentin dosing: 300 mg for age <65 years; 100-300 mg for age >65 years (Barash 9e, Table 55-6); renally cleared - adjust in renal failure

4. NMDA Receptor Antagonists

Ketamine:

Bolus: 0.1-0.35 mg/kg; Infusion: 0.1-1 mg/kg
Particularly beneficial in opioid-tolerant patients
Blocks central sensitization and wind-up
Avoid in psychiatric disturbance, cardiovascular/hepatic disease, pregnancy

Magnesium:

NMDA antagonist and calcium channel blocker
Bolus: 1-3 g; Infusion: 0.5-1 g
Reduces postoperative pain and opioid consumption
Side effects: hypotension, potentiation of NMB
Avoid in renal insufficiency, neuromuscular disorders, electrolyte imbalance

5. IV Lidocaine

Systemic anti-inflammatory and analgesic effect
Bolus: 0.5-1.5 mg/kg; Infusion: 1-1.5 mg/kg
In major abdominal surgery: associated with faster return of bowel function and decreased hospital stay (Morgan's 7e)
Opioid-sparing
Avoid combining with regional LA techniques; avoid in cardiac abnormalities, seizure disorder

6. Alpha-2 Agonists (Dexmedetomidine)

Bolus: 0.5-0.6 mcg/kg; Infusion: 0.3-1 mcg/kg/h
Opioid-sparing; useful as perineural adjunct for nerve blocks
Main side effects: hypotension and bradycardia

7. Opioids (Systemic)

"Despite the increasing use of nonopioid analgesic medications, the use of systemic opioids remains a cornerstone in the management of surgical pain." - Morgan's 7e
IV PCA provides superior analgesia and patient satisfaction vs PRN opioids
Oral opioids: important option but judicious prescribing essential given opioid epidemic
~6% of opioid-naive patients will continue filling prescriptions 3-6 months post-surgery

📘 PART 7: IV PATIENT-CONTROLLED ANALGESIA (IV PCA)

Miller's (p.11701-11704) provides a thorough discussion:

Principle: Negative feedback loop - when pain experienced, patient self-administers analgesic; when pain reduced, no further demands.

Advantages over PRN:

Compensates for wide interpatient variability
Avoids pharmacokinetic variability of IM injection
Eliminates administrative delays
Superior analgesia and patient satisfaction (meta-analysis confirmed)
Greater perceived control

Key PCA Settings:

Demand dose
Lockout interval
1-hour and 4-hour limits
Background infusion (see below)

Background infusion:

NOT recommended in opioid-naive adults - increases total dose and respiratory adverse events
Recommended for opioid-tolerant patients and paediatric patients

Rate of respiratory depression with IV PCA: ~1.5% - not more frequent than PRN opioids. Risk factors:

Background infusion
Advanced age
Concomitant sedatives
Obstructive sleep apnoea
Operator programming errors

📘 PART 8: NEURAXIAL ANALGESIA

Miller's (Table 77.3) - Properties of Neuraxial Opioids:

Property	Lipophilic (Fentanyl, Sufentanil)	Hydrophilic (Morphine, Hydromorphone)
Onset	Rapid (5-10 min)	Delayed (30-60 min)
Duration	Shorter (2-4 hours)	Longer (6-24 hours)
CSF spread	Minimal	Extensive
Site of action	Spinal < systemic	Primarily spinal
Delayed resp. depression	Primarily early, minimal delay	Both early AND delayed (>6h) possible
PONV/Pruritus	Lower incidence	Higher incidence

Clinical tip: Lipophilic opioids suit ambulatory patients needing rapid onset + moderate duration. Hydrophilic opioids (morphine) suit inpatient settings where longer analgesia is beneficial.

Epidural analgesia - for high thoracic/abdominal surgery: provides superior pain control, avoids systemic opioid respiratory depression. Combination of LA + opioid (e.g. bupivacaine + fentanyl) provides synergistic analgesia.

Monitoring Requirements for Postoperative Analgesia (Miller's Box)

Vital signs: temperature, HR, BP, RR, average pain score
Pain score at rest AND with activity
Respiratory status + level of sedation
Nausea/vomiting, pruritus, urinary retention
Motor block and sensory level assessment
Evidence of epidural haematoma

📘 PART 9: PREOPERATIVE DOSING TABLE (Barash 9e, Table 55-6)

Drug	Pre-op Dose	Comments
Acetaminophen	975 mg IV (adults)	Avoid in acute liver failure
Celecoxib	400 mg PO (<65y); 200 mg PO (>65y)	Avoid in pre-existing renal failure
Gabapentin	300 mg PO (<65y); 100-300 mg PO (>65y)	100% renal clearance - dose-adjust

🔵 TOPIC 2: FLUID MANAGEMENT IN MAJOR ABDOMINAL SURGERY

📘 PART 1: WHY FLUID MANAGEMENT MATTERS

"There is increasing evidence that perioperative fluid administration affects patient outcome following major surgery, with the quantity of fluid administered - either too restrictive or too liberal - being associated with increased incidence of postoperative complications." - Morgan's 7e, Ch. 48

Consequences of Fluid Overload (Liberal Therapy)

↓ Tissue oxygenation
Anastomotic leakage
Pulmonary oedema and pneumonia
Wound infection
Postoperative ileus
Prolonged hospitalisation
Weight gain of 3-6 kg - impairs postoperative mobilisation

Consequences of Excessive Restriction

The RELIEF Trial (largest RCT to date): Restrictive fluid therapy (≤5 mL/kg/h) vs liberal (8 mL/kg/h) with isotonic crystalloid - acute kidney injury occurred MORE frequently in the restrictive group
Hypovolaemia → organ hypoperfusion → AKI, anastomotic ischaemia

Current recommendation (Morgan's 7e): Target a positive fluid balance of 1-2 L at the end of surgery using isotonic balanced crystalloid solutions.

📘 PART 2: GOAL-DIRECTED FLUID THERAPY (GDFT)

"GDFT aims to avoid both hypovolaemia and fluid excess, and it is the optimal approach for fluid administration in high-risk surgical patients." - Morgan's 7e, p.2114

Principles of GDFT

Optimize hemodynamic parameters rather than using fixed rate protocols
Parameters monitored: HR, BP, stroke volume (SV), pulse pressure variation (PPV), stroke volume variation (SVV)
Guided by: pulse-contour arterial waveform analysis, oesophageal Doppler, transesophageal echocardiography

Evidence Base

Miller's (p.39): Closed-loop-assisted intraoperative GDFT during major abdominal surgery - reduction in intraoperative net fluid balance, associated with reduced postoperative complications
Multiple RCTs support GDFT in colorectal surgery, kidney transplant, and high-risk major surgery
Kidney transplant data (Miller's p.3218): GDFT group had lower rates of early graft dysfunction AND early cardiovascular events even with similar total fluid volumes

📘 PART 3: CHOOSING THE RIGHT FLUID

Morgan's First-Line Fluid Replacement Table (Table 48-3)

Physiological Requirement	Replace With	Amount
Insensible losses (closed abdomen)	Isotonic balanced crystalloid	0.5 mL/kg/h
Insensible losses (open abdomen)	Isotonic balanced crystalloid	1 mL/kg/h
Urine production	Crystalloid	Measured output
Blood loss	Iso-oncotic colloid	Estimated losses
Further preload deficit	Colloid	Per clinical/monitoring estimation

Crystalloids

Isotonic balanced crystalloids (Hartmann's/Ringer's Lactate, Plasmalyte) - preferred over normal saline
Normal saline risks: hyperchloraemic metabolic acidosis - avoid in high volumes
Miller's (p.5666): "The use of balanced salt solutions avoids hyperchloraemic metabolic acidosis and is likely preferable in most circumstances, including in patients with end-stage kidney disease."

Colloids

Replace intravascular losses (blood, plasma)
Iso-oncotic colloids used to replace physiologically important blood losses
Debate remains on HES vs albumin vs gelatin for specific indications

📘 PART 4: MONITORING INTRAOPERATIVE FLUID STATUS

Dynamic Predictors of Fluid Responsiveness (Best Indicators)

Parameter	Threshold for Fluid Responsiveness
Pulse Pressure Variation (PPV)	> 13%
Stroke Volume Variation (SVV)	> 10-15%
Oesophageal Doppler SV	↑ >10% after 200 mL fluid challenge

Limitations of static monitors:

CVP: unreliable for predicting fluid responsiveness - not recommended for guiding fluid therapy
Urine output: Miller's (p.5657) - "Intraoperative urine formation is not validated as a measure of the risk of postoperative renal dysfunction" - do NOT use as sole guide for fluid management

Point-of-Care Devices

PiCCO system (transpulmonary thermodilution)
LiDCO, PICCO, FloTrac (pulse contour analysis)
Oesophageal Doppler - non-invasive cardiac output
TEE - visual assessment of volume status + cardiac function

📘 PART 5: LAPAROSCOPIC ABDOMINAL SURGERY - SPECIAL CONSIDERATIONS

Barash 9e (p.3659) notes important considerations for laparoscopic major abdominal surgery:

Pneumoperitoneum creates volume shifts that alter expected perioperative fluid therapy goals
Classic hemodynamic indicators (HR, BP, CVP) may NOT be reliable during laparoscopy due to pneumoperitoneum and positioning
Urine output as a guide is limited during pneumoperitoneum
Fluid loading (40 mL/kg vs 15 mL/kg) in ambulatory laparoscopic cholecystectomy - unexpected improvements in postoperative pulmonary function, exercise capacity, and well-being
However, in patients with comorbidities undergoing major laparoscopic abdominal surgery, fluid loading may be deleterious

📘 PART 6: FLUID MANAGEMENT IN ENHANCED RECOVERY PROTOCOLS (ERAS)

Morgan's (p.1900-1904) integrates fluid management into ERAS:

The ERAS fluid strategy:

Avoid prolonged preoperative fasting - allow clear fluids up to 2h preoperatively
Carbohydrate loading reduces the preoperative fluid deficit
Intraoperative: GDFT with balanced crystalloids targeting SVV/PPV
Avoid positive balance >1-2 L by end of surgery
Early postoperative: switch to oral fluids; discontinue IV fluids early
Avoid routine nasogastric tubes - they increase ileus

Other ERAS elements that directly interact with fluid therapy:

Normothermia maintenance - reduces sympathetic activation and vasoconstriction
Optimal oxygenation - FiO₂ 40-60% intraoperatively; evidence on 80% oxygen inconclusive
PONV prophylaxis - ensures early oral fluid intake
Early mobilisation - improves tissue oxygenation and reduces DVT risk

📘 PART 7: RENAL PROTECTION DURING MAJOR ABDOMINAL SURGERY

Miller's (p.5663, Ch. 15):

Intraoperative hypotension and hypovolaemia are significant risk factors for AKI
AKI occurs in 5-25% of hospitalised patients; mortality of ICU AKI = 50-80%
Goal: maintain renal blood flow and perfusion pressure
Balanced crystalloids associated with lower rates of AKI vs saline
Volume overload itself is a risk factor for adverse outcomes in AKI
Preoperative creatinine >2 mg/dL: independent risk factor for cardiac complications

🟢 TOPIC 3: ANAESTHETIC MANAGEMENT OF COLLES FRACTURE

📘 PART 1: WHAT IS A COLLES FRACTURE?

A Colles fracture is a distal radius fracture with dorsal displacement and angulation, typically occurring after a fall on an outstretched hand. It is one of the most common fractures in adults, particularly in elderly women with osteoporosis.

Anaesthetic options:

Brachial plexus block (regional anaesthesia) - most ideal
IV Regional Anaesthesia (Bier Block) - simple and effective
General anaesthesia - usually not required; reserved for special circumstances
Haematoma block - simple local infiltration

📘 PART 2: BRACHIAL PLEXUS ANATOMY - THE FOUNDATION

Understanding the plexus is critical to choosing the right block level.

Morgan's (p.1861): "Local anesthetic may be deposited at any point along the brachial plexus, depending on the desired block effects: interscalene for shoulder and proximal humerus surgical procedures; and supraclavicular, infraclavicular, or axillary for surgeries distal to the mid-humerus."

BRACHIAL PLEXUS (C5-T1)
Roots → Trunks → Divisions → Cords → Branches (Terminal Nerves)

C5, C6 → Upper trunk
C7     → Middle trunk
C8, T1 → Lower trunk
             ↓
      Anterior/Posterior Divisions
             ↓
   Lateral, Medial, Posterior Cords
             ↓
Terminal Nerves: Musculocutaneous, Median, Ulnar, Radial, Axillary

Miller's (p.6235):

Above clavicle blocks (interscalene, supraclavicular) → target ventral rami, trunks, divisions
Below clavicle blocks (infraclavicular, axillary) → target cords and terminal nerves

📘 PART 3: CHOOSING THE RIGHT BLOCK FOR COLLES FRACTURE

For Colles fracture (distal radius, wrist): The wrist and hand are supplied by the lower trunk (C8-T1) - median, ulnar, and radial terminal nerves.

Block	Approach	Coverage	Suitable for Colles?
Interscalene	Roots/Upper trunks (C5-C7)	Shoulder, upper arm	❌ Misses C8-T1 (ulnar nerve)
Supraclavicular	Trunks/Divisions	Entire arm from mid-humerus distally	✅ Excellent
Infraclavicular	Cords	Elbow to hand	✅ Very good
Axillary	Terminal nerves	Elbow to hand	✅ Good
Bier Block (IVRA)	Venous absorption	Entire forearm/hand	✅ Simple, effective

Best choice for Colles fracture: Supraclavicular block (or infraclavicular/axillary)

📘 PART 4: SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK

Why supraclavicular for Colles?

Targets trunks and divisions - ensures coverage of all terminal nerves to the hand
Compact cluster of nerves near subclavian artery makes it reliable and complete
No phrenic nerve block (unlike interscalene) - safer in respiratory compromise

Technique (Barash 9e, p.2951)

Patient position: Supine, head turned ~45° to contralateral side

Nerve stimulation technique:

Midpoint of clavicle marked; needle entry point 1 cm posterior to midpoint in interscalene groove
2.5-5 cm, 22-gauge needle; initial insertion angle 45° cephalad
Acceptable responses: pectoralis, deltoid, biceps (upper trunk), triceps (upper/middle trunk), forearm, hand (lower trunk)
Current: 0.4 mA (0.1-0.3 ms)
Volume: 25-40 mL local anaesthetic

Ultrasound-guided technique:

Probe in coronal oblique plane at lateral end, just above clavicle
Identify subclavian artery; plexus sits superolateral to subclavian artery above first rib
Plexus appears as cluster of hypoechoic nodules
In-plane needle approach; spread around all trunks/divisions confirms placement

Risk: Pneumothorax (1%) - identify pleura clearly; never angle medially below 20°

📘 PART 5: AXILLARY BRACHIAL PLEXUS BLOCK

Suitable for: Forearm and hand surgery (elbow and below).

Morgan's (p.1862):

"Brachial plexus block at the level of the cords provides excellent anesthesia for procedures at or distal to the elbow."
The axillary, musculocutaneous, and medial brachial cutaneous nerves branch proximal to LA deposition - they are usually spared and must be independently blocked
The musculocutaneous nerve must be independently blocked to anaesthetise the lateral forearm

Technique:

Arm abducted 90°, elbow flexed 90°
Identify axillary artery by palpation/Doppler
Ultrasound: identify 4 terminal nerves around the artery (median anterosuperior, ulnar inferior, radial posterior, musculocutaneous within coracobrachialis)
Multiple injection technique: 5-8 mL per nerve
Total volume: ~30-40 mL

📘 PART 6: IV REGIONAL ANAESTHESIA (BIER BLOCK)

Morgan's (p.1862): "Intravenous regional anesthesia (Bier block) can provide intense surgical anesthesia for relatively short (45-60 min) surgical procedures on an extremity."

Principle: Local anaesthetic injected IV into an exsanguinated, double-cuff tourniquet-occluded limb distributes to nerve endings via venous system.

Technique for Colles Fracture

Place IV cannula in dorsum of hand on operative side
Apply double-cuff tourniquet to upper arm
Exsanguinate limb with Esmarch bandage (or elevation if fracture)
Inflate proximal cuff to 100 mmHg above systolic BP
Inject 0.5% prilocaine 40 mL (3 mg/kg) or 0.5% lidocaine slowly
Onset of dense anaesthesia within 5-10 minutes
After 20-25 min, inflate distal cuff (now over anaesthetised skin) then deflate proximal cuff
Minimum tourniquet inflation time: 25 minutes to prevent systemic LA toxicity on release

Advantages:

Technically simple
Rapid onset, complete block
Muscle relaxation
Bloodless field with tourniquet

Disadvantages/Risks:

Maximum duration ~90 minutes (tourniquet tolerance)
No postoperative analgesia
Risk of LAST if tourniquet deflated too early
Contraindicated in sickle cell disease, Raynaud's, peripheral vascular disease

📘 PART 7: INTERSCALENE BLOCK - WHY NOT FOR COLLES

Miller's (p.6236): "This technique is not recommended for forearm and hand surgery because blockade of the inferior trunk (C8 and T1) can be incomplete and require supplementation of the ulnar nerve for adequate surgical anesthesia in that distribution."

Morgan's (p.1861): "A properly performed interscalene block almost invariably blocks the ipsilateral phrenic nerve, so careful consideration must be given to patients with severe pulmonary disease or pre-existing contralateral phrenic nerve palsy. Bilateral interscalene blocks are ALWAYS contraindicated."

Phrenic nerve block considerations:

100% ipsilateral hemidiaphragmatic paralysis with interscalene
Reduces ipsilateral lung function by ~25%
Clinically significant in patients with COPD, obesity, contralateral phrenic nerve palsy

📘 PART 8: LOCAL ANAESTHETIC AGENTS FOR UPPER LIMB BLOCKS

Drug	Concentration	Volume	Onset	Duration	Comments
Lignocaine	1.5-2%	30-40 mL	Fast (10-15 min)	2-3 h	Good for Bier block
Bupivacaine	0.5%	25-35 mL	Medium (20-30 min)	6-12 h	Excellent for single-shot supraclavicular
Ropivacaine	0.5-0.75%	25-35 mL	Medium	6-12 h	Safer cardiac profile than bupivacaine
Levobupivacaine	0.5%	25-35 mL	Medium	8-14 h	Lowest cardiac toxicity

Adjuvants to prolong block duration:

Dexamethasone (4-8 mg perineurally or IV) - extends block by 6-8 hours
Dexmedetomidine (50-100 mcg perineurally) - extends and deepens block
Clonidine (150 mcg perineurally) - moderate prolongation

📘 PART 9: PATIENT CONSIDERATIONS FOR COLLES FRACTURE

Consideration	Relevance	Action
Elderly / frail	High prevalence of Colles; reduced LA dose needed	Reduce volume by 20-30%
Osteoporosis medications	May affect bone healing	Medication reconciliation
Anticoagulation	Common in elderly (AF, DVT prophylaxis)	Peripheral nerve blocks generally safe; avoid deep blocks if INR >1.5
NSAID use	Analgesic option	Caution in renal impairment, GI history
Comorbidities	Often multiple in elderly	Regional avoids GA hazards
Closed reduction	Short procedure, adequate sedation may be needed	Titrated IV sedation (midazolam + fentanyl/ketamine) alongside block

General anaesthesia - if regional contraindicated or refused:

LMA appropriate for most cases
Short-acting agents preferred (propofol, sevoflurane, desflurane)
Multimodal analgesia at emergence

🟠 TOPIC 4: PERIPHERAL VASCULAR DISEASE (PVD) - ANAESTHETIC MANAGEMENT

📘 PART 1: THE HIGH-RISK PVD PATIENT

Miller's (p.7919): "Major vascular surgery is particularly challenging to the anesthesiologist because these are high-risk operations in a patient population with a high prevalence of either overt or occult coronary artery disease, which is the leading cause of perioperative and long-term mortality after vascular surgery."

Key principle: "Maintenance of vital organ perfusion and function by the provision of stable perioperative hemodynamics is more important to overall outcome than is the choice of anesthetic drug or technique."

Coexisting Disease in PVD Patients (Miller's Ch. 52)

Coronary artery disease (CAD): Leading cause of perioperative mortality. In the Cleveland Clinic series of 1000 PVD patients: only 8.5% had normal coronary arteries; 60% had advanced/severe lesions (>70% stenosis)
Hypertension: Very common; systemic atherosclerosis
Diabetes mellitus: Peripheral and autonomic neuropathy; impaired wound healing; nephropathy
Chronic renal disease: Serum creatinine >2 mg/dL = independent risk factor for cardiac complications; CrCl <60 mL/min = independent predictor of short- and long-term mortality
COPD/Pulmonary disease: Smoking history; spirometry/PFTs needed
Cerebrovascular disease: Potential for perioperative stroke, particularly with carotid surgery

📘 PART 2: PREOPERATIVE ASSESSMENT

Cardiac Risk Stratification

Miller's (p.7925): CAD assessment should be focused on intermediate clinical risk patients:

Low risk (<1% cardiac risk): may proceed to surgery
Intermediate risk (1-5%): noninvasive testing may be warranted
High risk (>5%): further cardiac evaluation required

Important: Noninvasive testing should only be undertaken if it will change patient management. Prophylactic coronary revascularisation before vascular surgery has NOT been shown to reduce perioperative or long-term morbidity.

Miller's (p.7920): "Guidelines suggest that coronary intervention is rarely necessary to simply decrease the risk for surgery unless such intervention is indicated irrespective of the preoperative context."

Perioperative Medical Optimisation

Beta-blockers:

Continue chronic beta-blocker therapy throughout perioperative period
Do NOT use as primary treatment of tachycardia caused by hypovolaemia, anaemia, pain, or infection
If initiating de novo: start small dose and titrate over 7-10 days before planned surgery
Acute initiation of large-dose beta-blockade in the perioperative period should be avoided

Statins:

Continue perioperatively for all patients already on statin therapy
Benefits: anti-inflammatory, plaque-stabilising, antioxidant effects + lipid lowering
Can preserve renal function after aortic surgery; improve graft patency after lower extremity bypass

Antiplatelet therapy:

Requires individualised consideration; risk of surgical bleeding vs thrombotic risk
Aspirin generally continued; dual antiplatelet therapy management requires cardiologist input

📘 PART 3: INTRAOPERATIVE MONITORING

Miller's (p.7963): For major vascular surgery:

Arterial catheter (A-line) - routine in all patients undergoing aortic reconstruction; radial artery most commonly used
Contralateral non-invasive BP cuff as backup
Central venous access - central line + two large peripheral IVs
ST-segment analysis - computerised monitoring to detect myocardial ischaemia throughout perioperative period
Pulmonary artery catheter or TEE - for high-risk patients with severe LV dysfunction
Neurological monitoring - for carotid endarterectomy (SSEP, EEG, cerebral oximetry)
Temperature monitoring - postoperative hypothermia associated with many undesirable physiologic effects

📘 PART 4: AORTIC CROSS-CLAMPING PHYSIOLOGY

One of the most challenging aspects of major vascular surgery is managing the haemodynamic response to aortic cross-clamping and unclamping.

Physiologic Changes with Aortic Cross-Clamping (Miller's Box 52.1)

Haemodynamic changes (above clamp):

↑ Arterial blood pressure
↑ Left ventricular wall tension
↑ Pulmonary occlusion pressure and CVP
↑ Coronary blood flow
↓ Ejection fraction (severe LV impairment)
Segmental wall motion abnormalities

Below clamp:

↓ Arterial blood pressure
↓ Renal blood flow
↓ Cardiac output (with thoracic cross-clamping)

Metabolic changes:

↑ Mixed venous O₂ saturation (reduced consumption below clamp)
↑ Epinephrine and norepinephrine
Eventual metabolic acidosis (lactate accumulation below clamp)

Key insight (Miller's p.7948): Thoracic aortic cross-clamping causes a 155% increase in blood flow above the clamp due to splanchnic blood volume redistribution. The splanchnic veins (25% of total blood volume) are venoconstricted by catecholamines, actively forcing blood proximally.

Management Approach - Cross-Clamping

Vasodilators (nitroglycerin, nitroprusside) to control proximal hypertension
Reduce volatile anaesthetic concentration (↓ afterload)
Consider diverting circulatory support for thoracic cross-clamping

Management Approach - Unclamping (Box 52.3)

Correct all preoperative fluid deficits BEFORE unclamping
Replace all blood loss BEFORE unclamping
Reduce/discontinue vasodilators BEFORE unclamping
Decrease volatile anaesthetic concentration
Pre-emptive fluid bolus (~500 mL) immediately before infrarenal clamp release
For supraceeliac unclamping: more aggressive fluid administration needed
Have vasopressors ready (phenylephrine, norepinephrine)
Communicate with surgical team: gradual clamp release or digital compression if severe hypotension

📘 PART 5: CHOICE OF ANAESTHETIC TECHNIQUE

General Anaesthesia (GA)

Standard for major aortic surgery
Any volatile anaesthetic acceptable; isoflurane, sevoflurane commonly used
Volatile anaesthetics provide anaesthetic preconditioning benefit - cardioprotective
Maintain haemodynamic stability more important than agent choice

Regional Anaesthesia

Spinal or epidural anaesthesia is favoured for:
- Carotid endarterectomy (CEA) under LA/regional - allows neurological monitoring
- Lower limb peripheral bypass procedures
- Endovascular procedures (EVAR)
Benefits of regional for vascular surgery:
- Improved peripheral blood flow (sympathetic blockade → vasodilation → ↑ graft flow)
- ↓ DVT/thromboembolism risk
- ↓ Coagulation activation
- ↓ Pulmonary complications in patients with significant lung disease
- Better postoperative analgesia

Miller's (p.7942): "Although improved pulmonary outcome with regional anesthesia is not clear, patients with significant pulmonary disease may benefit from epidural techniques."

Combined GA + Epidural

Used for open aortic and major abdominal vascular procedures
Epidural provides excellent intraoperative and postoperative analgesia
Avoids systemic opioid respiratory depression
Facilitates early extubation

📘 PART 6: SPECIFIC PERIPHERAL VASCULAR PROCEDURES

A. Carotid Endarterectomy (CEA)

Special considerations:

Brain monitoring during cross-clamping: SSEP, EEG, cerebral oximetry (NIRS), or awake patient (best monitor)
Awake technique (cervical plexus block): allows real-time neurological assessment - gold standard for detecting shunt need
Shunting indicated if neurological deterioration occurs after carotid clamping
Blood pressure management: avoid hypotension (reduces cerebral perfusion) AND avoid hypertension (cerebral hyperperfusion syndrome post-procedure)
Key complication post-CEA: Hyperperfusion syndrome - headache, seizures, intracerebral haemorrhage
Haemodynamic instability common from carotid sinus manipulation

B. Lower Extremity Peripheral Bypass (Femoro-popliteal, Femoro-distal)

Anaesthetic options:

General anaesthesia (LMA or ETT)
Spinal anaesthesia - excellent for below-knee procedures; sympathetic block improves graft flow
Epidural anaesthesia - continuous; useful for longer procedures

Regional advantages in lower limb:

Sympathectomy → peripheral vasodilation → ↑ graft perfusion
↓ DVT risk
Superior postoperative analgesia

Monitoring:

A-line for haemodynamic monitoring
Consider TEE/oesophageal Doppler in high-risk cardiac patients

Critical intraoperative events:

Heparinisation: systemic heparin given before clamping (usually 5000-10,000 IU); protamine reversal after clamp release if required
Reperfusion injury: ischaemia-reperfusion after limb revascularisation → metabolic acidosis, hyperkalaemia, myoglobinaemia; prepare for these

C. Endovascular Aortic Repair (EVAR)

Less physiologically stressful than open repair
Options: GA, regional (spinal/epidural), or monitored anaesthesia care (MAC) with LA
Endoleak is a complication specific to EVAR - inability to exclude aneurysm sac from arterial blood flow
Lower haemodynamic instability; no cross-clamping physiology
Blood loss generally much less than open repair
Shorter ICU stay

📘 PART 7: RENAL PROTECTION IN VASCULAR SURGERY

Miller's (p.7932-7933):

Prevalence of acute renal failure: ~7% after abdominal aortic reconstruction
Renal blood flow decreases with any level of aortic cross-clamping
Embolic plaque showered into renal arteries especially with suprarenal clamps

Protective strategies:

Maintain adequate intravascular volume and cardiac output before/during/after clamping
Mannitol (0.5 g/kg IV before cross-clamping): osmotic diuretic, free radical scavenger
Selective renal artery perfusion during suprarenal clamping
Avoid nephrotoxins (contrast, aminoglycosides, NSAIDs)
Moderate hypothermia provides some renal protection during prolonged ischaemia
Sodium bicarbonate: correct acidaemia that may exacerbate ischaemic injury

📘 PART 8: POSTOPERATIVE MANAGEMENT OF PVD PATIENTS

Pulmonary Complications

Miller's (p.7932): "Pulmonary complications in the postoperative period are difficult to avoid. Incentive spirometry and CPAP do provide benefit."

Preoperative optimisation: bronchodilators, antibiotics, steroids as indicated
Regional anaesthesia/epidural analgesia → avoids systemic opioid respiratory depression
Early extubation (awake, warm, comfortable) where possible

Cardiovascular Complications

Continue perioperative ST-segment monitoring postoperatively
Beta-blocker continuation
Early detection of perioperative MI (peaks day 2-3 post-thoracotomy/major vascular surgery)

Vascular Graft Complications

Monitor for graft thrombosis: limb colour, temperature, pulses, Doppler
Anticoagulation monitoring and management
Wound care in diabetic/ischaemic limbs

📘 SUMMARY TABLES

Quick Reference: Anaesthetic Technique Selection for PVD

Procedure	Preferred Technique	Monitoring Essentials
Open AAA repair	GA ± epidural	A-line, CVP/PAC or TEE, temp
EVAR	GA or spinal/regional or MAC	A-line, TEE optional
Carotid endarterectomy	Regional (cervical plexus block) or GA + EEG/SSEP	Cerebral oximetry, neurological monitoring
Femoro-popliteal bypass	Spinal/epidural or GA	A-line, standard monitors
Lower limb embolectomy	Spinal or GA	Standard monitors
Peripheral endovascular	MAC or spinal	Standard + A-line

Key Threshold Values for PVD Patients

Marker	Threshold	Clinical Significance
Serum creatinine	> 2 mg/dL	Independent risk factor for cardiac complications
Creatinine clearance	< 60 mL/min	Independent predictor of short- and long-term mortality
CAD stenosis	> 70%	Advanced disease; consider coronary workup
Baseline PaCO₂	> 45 mmHg	Higher risk for postoperative morbidity
Perioperative BP target	Maintain ±20% of baseline	Avoid hypotension AND hypertension

📚 Sources

Miller's Anesthesia, 2-Volume Set, 10e - Chapters 42 (Regional Anesthesia), 48 (Fluid Management), 52 (Vascular Surgery), 77 (Acute Pain Management)
Morgan and Mikhail's Clinical Anesthesiology, 7e - Chapters 23, 31, 46 (Regional), 48 (ERAS/Fluid/Multimodal Analgesia)
Barash, Cullen, and Stoelting's Clinical Anesthesia, 9e - Chapters 15 (Laparoscopic), 36 (Regional), 55 (Acute Pain Management)

This is a shared conversation. Sign in to Orris to start your own chat.